Clearmind Medicine (CMND) Return on Assets [ROA] (2023 - 2026)
Clearmind Medicine (CMND) reported Return on Assets [ROA] of -61.59% for fiscal Q2 2026 (quarter ended Apr 30, 2026), up 20.59 percentage points from -82.18% a year earlier.
Powered by 
Analysis
Clearmind Medicine (CMND) Return on Assets [ROA] (2023 - 2026) Analysis & Trends
For FY2024 (ended Oct 31, 2024), Clearmind Medicine posted Return on Assets [ROA] of -79.56%, up 174.75 percentage points from FY2023.
- By fiscal year, Return on Assets [ROA] came in at -254.31% in FY2023 (+25.45 pp) and -279.76% in FY2022.
- The fiscal Q2 2026 figure ranks as the highest quarterly Return on Assets [ROA] in data going back to fiscal Q1 2023.
- Year over year, Return on Assets [ROA] gained in five of the last six quarters, with an average year-over-year change of +23.04 percentage points.
- The high point for year-over-year Return on Assets [ROA] in five years was fiscal Q1 2024 (a gain of 147.86 percentage points); the low point was fiscal Q2 2025 (a drop of 9.11 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,199.50 Bn | 1,168.08 Bn | 19.71 Bn | 20.64% |
| 2 | Johnson & Johnson | 635.17 Bn | 555.03 Bn | 17.30 Bn | 8.08% |
| 3 | AbbVie | 504.69 Bn | 477.85 Bn | 12.70 Bn | 4.65% |
| 4 | Merck | 358.43 Bn | 312.86 Bn | 12.21 Bn | 2.45% |
| 5 | Novartis Ag | 288.36 Bn | 252.75 Bn | 11.24 Bn | 10.60% |
| 6 | Astrazeneca | 265.78 Bn | 239.54 Bn | 12.86 Bn | 9.10% |
| 7 | Amgen | 237.46 Bn | 192.86 Bn | 7.24 Bn | 9.29% |
| 8 | Gilead Sciences | 193.65 Bn | 167.76 Bn | 6.22 Bn | -6.13% |
| 9 | Pfizer | 171.05 Bn | 118.00 Bn | 10.94 Bn | 2.14% |
| 10 | Clearmind Medicine | 9,390.99 | -39.89 Mn | - | -47.70% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -47.70% |
| Apr 30, 2026 | -61.59% |
| Jan 31, 2026 | -77.09% |
| Oct 31, 2025 | -76.74% |
| Jul 31, 2025 | -88.61% |
| Apr 30, 2025 | -82.18% |
| Jan 31, 2025 | -71.65% |
| Oct 31, 2024 | -68.12% |
| Jul 31, 2024 | -99.18% |
| Apr 30, 2024 | -73.07% |
| Jan 31, 2024 | -100.79% |
| Oct 31, 2023 | -165.12% |
| Jul 31, 2023 | -116.67% |
| Apr 30, 2023 | -132.04% |
| Jan 31, 2023 | -247.95% |
API Access
Clearmind Medicine Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();